Microsatellite instability analysis and its correlation with hMLH1 repair gene hypermethylation status in esophageal pathologies including cancers

Cancer Biomarkers

Volumn 7, Issue 1, 2010, Pages 1-10

  Vasavi, M ^a   Kiran, V ^a   Ravishankar, B ^a   Prabhakar, B ^b   Ahuja, Y R ^c   Hasan, Q ^a,d  

^a KAMINENI HOSPITALS   (India)

^b Gastroenterology Unit   (India)

^c Vasavi Medical and Research Centre   (India)

^d Bhagwan Mahavir Medical Research Centre   (India)

Author keywords

BAT25; D3S1313; esophageal pathologies; hMLH1; methylation; Microsatellite loci

Indexed keywords

BAT25 PROTEIN; BATR2 PROTEIN; PROTEIN MLH1; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DYSPEPSIA; DYSPHAGIA; ENDOSCOPY; ESOPHAGUS; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PRIORITY JOURNAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MICROSATELLITE INSTABILITY; NUCLEAR PROTEINS; PRECANCEROUS CONDITIONS; PROMOTER REGIONS, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 78149258075     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/CBM-2010-0135     Document Type: Article

References (62)

1. V. Gajalakshmi, R. Swaminathan and V. Shanta, An independent survey to assess completeness of registration: Population based cancer registry, Chennai, India, Asian Pac J Cancer Prev 2 (2001), 179-183.
2. S. Chitra, L. Ashok, L. Anand, V. Srinivasan and V. Jayanthi, Risk factors for esophageal cancer in Coimbatore, southern India a hospital-based case-control study, Indian J Gastroenterol 23 (2004), 19-21.
3. Y. Kagawa, K. Yoshido, T. Hirai, T. Toge, H. Yokozaki, W. Yasui and E. Tahara, Microsatelllite Instability in Squamous cell carcinoma and dysplasias of the esophagus, AntiCancer Res 20 (2000), 213-218.
4. G.Y. Yang, Accomplishments in 2008 in the Management of Esophageal Cancer, Gastrointest Cancer Res 5(Supplement 2) (3 Sep-Oct 2009), S53-S57.
5. D. Falkenback, J. Johansson, B. Halvarsson and M. Nilbert, Defective mismatch-repair as a minor tumorigenic pathway in Barrett esophagus-associated adenocarcinoma, Cancer Genet Cytogenet 157 (2005), 82-86.
6. R. Kim, J.L. Weissfeld, J.C. Reynolds and L.H. Kuller, Etiology of Barrett's metaplasia and esophageal adenocarcinoma, Cancer Epidemiol Biomarkers Prev 6 (1997), 369-377.
7. D. Tautz, Notes on the definition and nomenclature of tandem-ly repetitive DNA sequences, Exper 67(Suppl. Basel) (1993), 21-28.
8. S. Oda, Y. Maehara, Y. Ikeda, E. Oki, A. Egashira, Y. Okamu-ra, I. Takahashi, Y. Kakeji, Y. Sumiyoshi, K. Miyashita, Y. Ya-mada, Y. Zhao, H. Hattori, K. Taguchi, T. Ikeuchi, T. Tsuzuki, M. Sekiguchi, P. Karran and M. A. Yoshida, Two modes of mi-crosatellite instability in human cancer: differential connection of defective DNA mismatch repair to dinucleotide repeat instability, Nucleic Acids Res 33 (2005), 1628-1636.
9. F.X. Liu, X.P. Huang, X. Xu, Y. Cai, Y.L. Han, R.L. Wu, M. Wu, Q.M. Zhan and M.R. Wang, Alterations of MLH1 and microsatellite instability in esophageal squamous cell carcinomas, Yi Chuan Xue Bao 32 (2005), 234-242. (Pubitemid 40602046)
10. M. Ohta, H. Inoue, M.G. Cotticelli et al., The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers, Cell 84 (1996), 587-597.
11. S. Tanaka, M. Mori, K. Mafune et al., A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable esophageal carcinoma, Br J Cancer 82 (2000), 1557-1560.
12. Y. Shimada, F. Sato, G. Watanabe, S. Yamasaki, M. Kato, M. Maeda and M. Imamura, Loss of fragile histidine triad gene expression is associated with progression of esophageal squamous cell carcinoma, but not with the patient's prognosis and smoking history, Cancer 89 (2000), 5-11.
13. A. Ichikawa, K. Sugano and S. Fujita, DNA Variants of BAT-25 in Japanese, a Locus Frequently Used for Analysis of Mi-crosatellite Instability, Japanese J Clin Oncol 31 (2001), 346-348.
14. K. Mimori, H. Inoue, T. Shiraishi et al., Microsatellite instability is often observed in esophageal carcinoma patients with allelic loss in the FHIT/FRA3B locus, Oncology 64 (2003), 275-259.
15. T.H. Cheng, P.K. Hsu, A.F. Li, I.C. Hung, M.H. Huang, H.S. Hsu, Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma, J Cancer Res Clin Oncol 135(11) (Nov. 2009), 1577-1582.
16. E.P. Xing, Y. Nie, D.L. Wang et al., Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China, Carcinogenesis 20 (1999), 77-84.
17. G.R. Anderson, Genomic instability in cancer, Current Science 81 (2001), 501-507.
18. Y. Nie, J. Liao, X. Zhao, Y. Song, G.Y. Yang, L.D. Wang and C.S. Yang, Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma, Carcinogenesis 23 (2002), 1713-1720.
19. E. Alvino, G. Marra, E. Pagani, S. Falcinelli, R. Pepponi, C. Perrera, R. Haider, D. Castiglia, G. Ferranti, E. Bonmassar, J. Jiricny, G. Zambruno and S. D'Atri, High-frequency mi-crosatellite instability is associated with defective DNA mismatch repair in human melanoma, J Invest Dermatol 118 (2002), 79-86.
20. J.M. Cunningham, E.R. Christensen, D.J. Tester C.Y. Kim, P.C. Roche, L.J. Burgart and S.N. Thibodeau, Hypermethyla-tion of the hMLH1 promoter in colon cancer with microsatel-lite instability, Cancer Res 58 (1998), 3455-3460.
21. M. Matsushita, S. Takeuchi, Y. Yang, N. Yoshino, K. Tsukasa-ki, H. Taguchi, H.P. Koeffler and H. Seo, Methylation of the MLH1 gene in hematological malignancies, Oncol Rep 14 (2005), 191-194.
22. H. Geddert, S. Kiel, E. Iskender, A.R. Florl, T. Krieg, S. Vossen, H.E. Gabbert and M. Sarbia, Correlation of hMLH1 and HPP1 hypermethylation in gastric, but not in esophageal and cardiac adenocarcinoma, Int J Cancer 110(2) (10 Jun 2004), 208-211.
23. S.J. Meltzer, J. Yin, B. Manin, M.G. Rhyu, J. Cottrell, E. Hudson, J.L. Redd, M.J. Krasna, J.M. Abraham and B.J. Reid, Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's associated esophageal adenocarcinomas, Cancer Res 54 (1994), 3379-3382.
24. C.M. Gleeson, J.M. Sloan, J.A. McGuigan, A.J. Ritchie, J.L. Weber and S.E. Russell, Widespread microsatellite instability occurs infrequently in adenocarcinoma of the gastric cardia, Oncogene 12 (1996), 1653-1662.
25. S.C. Evans, A. Gillis, L. Geldenhuys, N.M. Vaninetti, D.A. Malatjalian, G.A. Porter, D.L. Guernsey and A.G. Casson, Mi-crosatellite instability in esophageal adenocarcinoma, Cancer Lett 212 (2004), 241-251.
26. Q. Hasan, M. Vasavi and Y.R. Ahuja, (CTG)n expansion at the DMPK locus seen only in muscle tissue: A novel case, Indian J Exptl Biol 42 (2004), 937-940.
27. B. Ruger, K.J. Erb, Y. He, J.M. Jane, P.P. Davis and Q. Hasan, Glomerulosclerosis of IL-4 transgenic mice is not immune mediated, Euro J Immunol 30 (2000), 2698-2703.
28. Y. Wang, J. Irish, C. Macmillan, D. Brown, Y. Xuan, C. Boy-ington, P. Gullane and S. Kamel-Reid, High frequency of mi-crosatellite instability in young patients with head and neck squamous cell carcinoma: lack of involvement of the mismatch repair genes hMLH1 and hMSH2, Int J Cancer 93 (2001), 353-360.
29. M. Vasavi, P. Shivani, G. Kusumanjali, B. Prabhakar, B. Ravi Shankar, R. Prasad, Y.R. Ahuja and Q. Hasan, DNA Methyla-tion in esophageal pathologies including cancer: special reference to hMLH1 gene promoter status, Tumori 92 (2006), 155-162.
30. C.R. Boland, S.N. Thibodeau, S.R. Hamilton, D. Sidransky, J.R. Eshleman, R.W. Burt, S.J. Meltzer, M.A. Rodriguez-Bigas, R. Fodde, G.N. Ranzani and S. Srivastava, A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer, Cancer Res 58 (1998), 5248-5257.
31. W.S. Choi, J.R. Choi, Y.J. Chung, K.M. Kim and M.G. Rhyu, Prognostic implications of microsatellite genotypes in gastric carcinoma, Int J Cancer 89 (2000), 378-383.
32. F.R. Grati, S.M. Sirchia, I. Garagiola, E. Sironi, S. Galioto, F. Rossella, P. Serafini, F. Dulcetti, A. Bozzetti, R. Brusati and G. Simoni, Losses of heterozygosity in oral and oropharyngeal epithelial carcinomas, Cancer Genet Cytogenet 118 (2000), 57-61.
33. M. Yanagi, G. Keller, J. Mueller, A. Walch, M. Werner, H.J. Stein, J.R. Siewert and H. Hofler, Comparison of loss of het-erozygosity and microsatellite instability in adenocarcinomas of the distal esophagus and proximal stomach, Virchows Arch 437 (2000), 605-610.
34. M.S. Sawhney, W.D. Farrar, S. Gudiseva, D.B. Nelson, F.A. Lederle, T.S. Rector and J.H. Bond, Microsatellite instability in interval colon cancers, Gastroenterology 131 (2006), 1700-1705.
35. N. Kubo, M. Yashiro, M. Ohira, T. Hori, I. Fujiwara and K. Hirakawa, Frequent microsatellite instability in primary esophageal carcinoma associated with extraesophageal primary carcinoma, Int J Cancer 114 (2005), 166-173.
36. J.C. Cai, D. Liu, K.H. Liu, H.P. Zhang, S. Zhong and N.S. Xia, Microsatellite alterations in phenotypically normal esophageal squamous epithelium and metaplasia-dysplasia-adenocarcinoma sequence, World J Gastroenterol 14 (2008), 4070-4076.
37. J.A. Jankowski, N.A. Wright, S.J. Meltzer, G. Triadafilopou-los, K. Geboes, A.G. Casson, D. Kerr and L.S. Young, Molecular evolutionofthe metaplasia-dysplasia-adenocarcinoma sequence in the esophagus, Am J Pathol 154 (1999), 965-973.
38. F.Muzeau, J.F. Fléjou, J. Belghiti, G. Thomas and R. Hamelin, Infrequent microsatellite instability in oesophageal cancers, Br J Cancer 75(9) (1997), 1336-1339.
39. Y. Matsumoto, T. Nagasaka, T. Kambara, N. Hoshizima, J. Murakami, H. Sasamoto, M. Hosokawa, Y. Naomoto, H. Isozaki, K. Shimizu, N. Tanaka and N. Matsubara, Microsatel-lite instability and clinicopathological features in esophageal squamous cell cancer, Oncol Rep 18(5) (Nov 2007), 1123-1127.
40. H. Shiraishi, T. Mikami, T. Yoshida, S. Tanabe, N. Kobayashi, M. Watanabe and I. Okayasu, Early genetic instability of both epithelial and stromal cells in esophageal squamous cell carcinomas, contrasted with Barrett's adenocarcinomas, J Gas-troenterol 41 (2006), 1186-1196.
41. M. Hayashi, G. Tamura, Z. Jin, I. Kato, M. Sato, Y. Shibuya, S. Yang and T. Motoyama, Microsatelllite instability in esophageal squamous cell carcinoma is not associated with hMLH1 promoter hypermethylation, Pathol Int 53 (2003), 270-276.
42. N. Kubo, M. Yashiro, M. Ohira, T. Hori, I. Fujiwara and K. Hirakawa, Frequent microsatellite instability in primary esophageal carcinoma associated with extraesophageal primary carcinoma, Int J Cancer 114(2) (20 Mar 2005), 166-173.
43. N. Uchida, H. Kumimoto, K. Nishizawa, S. Tokumasu, H. Harada, Y. Shimada and K. Ishizaki, Mismatch repair and mi-crosatellite instability in esophageal cancer cells, Int J Cancer 91 (2001), 687-691.
44. W. Vogel, R. Lammers, J. Huang and A. Ullrich, Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation, Science 259 (1993), 1611-1614.
45. S.J. Hines, C. Organ, M.J. Kornstein and G.W. Krystal, Co-expression of the c-kit and stem cell factor genes in breast carcinomas, Cell Growth Differ 6 (1995), 769-779.
46. M.Z. Ratajczak, S.M. Luger and A.M. Gewirtz, The c-kit proto-oncogene in normal and malignant human hematopoiesis, Int J Cell Cloning 10 (1992), 205-214.
47. S. Ogasawara, C. Maesawa, G. Tamura and R. Satodate, Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma, Cancer Res 55 (1995), 891-894.
48. M. Mori, K. Mimori, Shiraishi T, H. Alder, H. Inoue, Y. Tana-ka, K. Sugimachi, K. Huebner and C.M. Croce, Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus, Cancer Res 60 (2000), 1177-1182.
49. G. Sozzi, M.L. Veronese, M. Negrini, R. Baffa, M.G. Cotti-celli, H. Inoue, S. Tornielli, S. Pilotti, L. De Gregorio, U. Pas-torino, M.A. Pierotti, M. Ohta, K. Huebner and C.M. Croce, The FHIT gene at 3p14.2 is abnormal in lung cancer, Cell 85 (1996), 17-26. (Pubitemid 26116803)
50. M. Ohta, H. Inoue, M.G. Cotticelli, K. Kastury, R. Baffa, J. Palazzo, Z. Siprashvili, M. Mori, P. McCue, T. Druck, C.M. Croce and K. Huebner, The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t (3;8) breakpoint, is abnormal in digestive tract cancers, Cell 84 (1996), 587-597.
51. M. Campiglio, Y. Pekarsky, S. Menard, E. Tagliabue, S. Pilotti and C.M. Croce, FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease, Cancer Res 59 (1999), 3866-3869.
52. Y. Shimada, F. Sato, G. Watanabe, S. Yamasaki, M. Kato, M. Maeda and M. Imamura, Loss of Fragile Histidine Triad gene expression is associated with progression of esophageal squamous cell carcinoma, but not with the patient's prognosis and smoking history, Cancer 29 (2000), 5-11.
53. L. Sard, P. Accornero, S. Tornielli, D. Delia, G. Bunone, M. Campiglio, M.P. Colombo, M. Gramegna, C.M. Croce, M.A. Pierotti and G. Sozzi, The tumor suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control, Proc Natl Acad Sci USA 96 (1999), 8489-8492.
54. F. Pichiorri, T. Palumbo, S.S. Suh, H. Okamura, F. Trapasso, H. Ishii, K. Huebner and C.M. Croce, Fhit tumor suppressor: guardian of the preneoplastic genome, Future Oncol 4 (2008), 815-824.
55. J.A. Green, R. Amaro and J.S. Barkin, Symptomatic gastroe-sophageal reflux as a risk factor for esophageal adenocarcino-ma. Dig Dis Sci 12 (2000), 2367-2368.
56. M. Pinto, C. Oliveira, J.C. Machado, L. Cirnes, J. Tavares, F. Carneiro, R. Hamelin, R.Hofstra, R. Seruca and M.S. Simoes, MSI-L Gastric Carcinomas Share the hMLH1 Methylation Status of MSI-H Carcinomas but Not Their Clinicopathologi-cal Profile, Lab Invest 80 (2000), 1915-1923.
57. T.M. Pawlik, C.P. Raut and M.A. Rodriguez-Bigas, Colorectal carcinogenesis: MSI-H versus MSI-L, Dis Markers 20 (2004), 199-206.
58. P. Peltomäki, DNA mismatch repair and cancer, Mutat Res 488 (2001), 77-85.
59. K. Amara, M. Trimeche, S. Ziadi, A. Laatiri, M. Hachana and S. Korbi, Prognostic significance of aberrant promoter hyper-methylation of CpG islands in patients with diffuse large B-cell lymphomas, Annals of Oncology Adv Access, pub online, 6 June 2008.
60. D. Furlan, R. Cerutti, S. Uccella, S. La Rosa, E. Rigoli, A. Genasetti andC. Capella, Different Molecular Profiles Characterize Well-Differentiated Endocrine Tumors and Poorly Differentiated Endocrine Carcinomas of the Gastroenteropancre-atic Tract, Clin Can Res 10 (2004), 947.
61. N.W. Wilkinson, J.D. Black, E. Roukhadze, D. Driscoll, S. Smiley, H. Hoshi, J. Geradts, M. Javle and M. Brattain, Epidermal growth factor receptor expression correlates with his-tologic grade in resected esophageal adenocarcinoma. J Gastrointes Surgery 8 (2004), 448-453.
62. J.C. Goeminne, T. Guillaume and M. Symann, Pitfalls in the detection of disseminated non-hematological tumor cells, Annals of Oncol 11 (2000), 785-792.